
Daxor Corporation
DXR · NASDAQ · Healthcare / Medical Instruments & Supplies
8.48USD+0.02 (+0.24%)
Price History
Full chartMarket Stats
Previous Close8.46
Open8.55
Day Range8.35 – 8.59
52-Week Range8.56 – 14.76
Volume16.80K
Market Cap64.28M
P/E (TTM)6.51
Forward P/E64.52
EPS1.69
Dividend Yield0.00%
Beta0.26
50-Day Avg10.60
200-Day Avg11.15
About
Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation operates as a subsidiary of Estate Of Joseph Feldschuh.
Company Details
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CEOMr. Michael Richard Feldschuh
- Employees0
- Headquarters109 Meco Lane, Oak Ridge, TN, United States, 37830, USA
- Websitehttps://www.daxor.com
Leadership
- Mr. Michael Richard FeldschuhChairman, President & CEO · b. 1969
- Mr. Robert J. Michel C.P.A., M.B.A.CFO, Chief Compliance Officer & Corporate Secretary · b. 1957
- Mr. Jonathan Adam FeldschuhChief Scientific Officer & Director · b. 1965
- Dr. John Lynn Jefferies FACC, M.B.A., M.D., M.P.H.Chief Medical Officer · b. 1970
- Ms. Linda CooperVice President of Development & Operations
- Ms. Kathryn A. KornafelSenior VP of Marketing & Commercial Development
- Ms. Annette Plishka B.S.N.Senior Vice President of Commercialization
Financials
Income Statement
Balance Sheet
Cash Flow
Earnings
Key Statistics & Ratios
Market Cap64.28M
Enterprise Value42.93M
Trailing P/E6.51
Forward P/E64.52
PEG Ratio0.00
Price / Sales2049.71
Price / Book1.22
EPS1.69
Book Value9.07
Revenue (TTM)31.36K
Gross Profit (TTM)31.36K
Profit Margin19861.41%
Operating Margin-4529.86%
Return on Equity14.24%
Return on Assets-2.63%
Shares Outstanding5.84M
Shares Float2.90M
Beta0.26
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%
Analyst Ratings
Strong Buy
Based on 2 analystsTarget 20.00
- Strong Buy1
- Buy1
Ownership Breakdown
- Institutions
- 7.02%
- Insiders
- 49.50%
- Retail / Other
- 43.48%
Top Institutional Holders
- Thompson, Siegel & Walmsley LLC241.77K4.14%
- Vanguard Capital Management, LLC48.28K0.83%
- Aristides Capital LLC41.69K0.71%
- Renaissance Technologies Corp28.01K0.48%
- Susquehanna International Group, LLP13.72K0.23%
- NANO CAP NEW MILLENNIUM GROWTH FUND L P12.50K0.21%
- Crescent Grove Advisors, LLC12.42K0.21%
- SBI Securities Co Ltd3.13K0.05%
- Morgan Stanley - Brokerage Accounts3.09K0.05%
- Vanguard Fiduciary Trust Co1.04K0.02%
- Advisor Group Holdings, Inc.5000.01%
- Tower Research Capital LLC1090.00%
- JPMorgan Chase & Co10.00%
- Wells Fargo & Co00.00%
- UBS Group AG00.00%
- Empirical Financial Services, LLC00.00%
Top Fund Holders
- Vanguard MStar Total Stk Mkt Idx Invest48.83K0.84%
- Gabelli Global Mini Mites I4000.01%
Dividends
20181×
0.03Jan 5, 2018
20171×
0.03Dec 20, 2017
20161×
0.03Dec 20, 2016
20151×
0.04Dec 18, 2015
20141×
0.03Dec 4, 2014
20131×
0.05Dec 5, 2013
20122×
0.10Dec 7, 20120.10Aug 10, 2012
20112×
0.10Nov 16, 20110.15May 27, 2011
20103×
0.65Dec 14, 20100.25Sep 13, 20100.10May 27, 2010
20094×
1.00Dec 8, 20090.25Aug 21, 20090.10Jun 11, 20090.10May 27, 2009
20083×
1.00Dec 10, 20080.25Oct 31, 20080.25Jul 24, 2008
19981×
0.13Apr 28, 1998
19971×
0.50Apr 28, 1997